A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia: Analysis at two time points

Ruben A. Mesa, Heather Powell, Terra Lasho, Goron W. DeWald, Rebecca McClure, Ayalew Tefferi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Serial analysis for the activating JAK2V617F mutation performed in 44 patients with myelofibrosis with myeloid metaplasia showed no interval change in 88% (22/25) of patients over a median interval of 18.6 months. The increase in JAK2 expression observed in three patients did not correspond to disease progression or leukemic transformation.

Original languageEnglish (US)
Pages (from-to)415-416
Number of pages2
JournalHaematologica
Volume91
Issue number3
StatePublished - Mar 2006

Fingerprint

Primary Myelofibrosis
Longitudinal Studies
Mutation
Disease Progression

Keywords

  • JAK2
  • Leukemic transformation
  • Myelofibrosis with myeloid metaplasia
  • Myeloproliferative disorders

ASJC Scopus subject areas

  • Hematology

Cite this

A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia : Analysis at two time points. / Mesa, Ruben A.; Powell, Heather; Lasho, Terra; DeWald, Goron W.; McClure, Rebecca; Tefferi, Ayalew.

In: Haematologica, Vol. 91, No. 3, 03.2006, p. 415-416.

Research output: Contribution to journalArticle

Mesa, Ruben A. ; Powell, Heather ; Lasho, Terra ; DeWald, Goron W. ; McClure, Rebecca ; Tefferi, Ayalew. / A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia : Analysis at two time points. In: Haematologica. 2006 ; Vol. 91, No. 3. pp. 415-416.
@article{892c85301e7940599903f4d7ba37cfdf,
title = "A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia: Analysis at two time points",
abstract = "Serial analysis for the activating JAK2V617F mutation performed in 44 patients with myelofibrosis with myeloid metaplasia showed no interval change in 88{\%} (22/25) of patients over a median interval of 18.6 months. The increase in JAK2 expression observed in three patients did not correspond to disease progression or leukemic transformation.",
keywords = "JAK2, Leukemic transformation, Myelofibrosis with myeloid metaplasia, Myeloproliferative disorders",
author = "Mesa, {Ruben A.} and Heather Powell and Terra Lasho and DeWald, {Goron W.} and Rebecca McClure and Ayalew Tefferi",
year = "2006",
month = "3",
language = "English (US)",
volume = "91",
pages = "415--416",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",

}

TY - JOUR

T1 - A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia

T2 - Analysis at two time points

AU - Mesa, Ruben A.

AU - Powell, Heather

AU - Lasho, Terra

AU - DeWald, Goron W.

AU - McClure, Rebecca

AU - Tefferi, Ayalew

PY - 2006/3

Y1 - 2006/3

N2 - Serial analysis for the activating JAK2V617F mutation performed in 44 patients with myelofibrosis with myeloid metaplasia showed no interval change in 88% (22/25) of patients over a median interval of 18.6 months. The increase in JAK2 expression observed in three patients did not correspond to disease progression or leukemic transformation.

AB - Serial analysis for the activating JAK2V617F mutation performed in 44 patients with myelofibrosis with myeloid metaplasia showed no interval change in 88% (22/25) of patients over a median interval of 18.6 months. The increase in JAK2 expression observed in three patients did not correspond to disease progression or leukemic transformation.

KW - JAK2

KW - Leukemic transformation

KW - Myelofibrosis with myeloid metaplasia

KW - Myeloproliferative disorders

UR - http://www.scopus.com/inward/record.url?scp=33645422003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645422003&partnerID=8YFLogxK

M3 - Article

C2 - 16531268

AN - SCOPUS:33645422003

VL - 91

SP - 415

EP - 416

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -